Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-19

Clinical Trial Update: Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the dexamethasone intravitreal implant for persistent diabetic macular edema has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: California Retina Consultants | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED | Results posted: 2019-02-19